Not applicableStudy completedNCT00900328What this trial is testingStudy of Tumor Samples From Patients With Lung CancerWho this might be right forLung Cancer Alliance for Clinical Trials in Oncology 280
Testing effectiveness (Phase 2)WithdrawnNCT00469976What this trial is testingEnzastaurin, Carboplatin, and Gemcitabine With or Without Bevacizumab in Treating Patients With Recurrent, Stage IIIB, or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Study completedNCT00407550What this trial is testingPemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer Mayo Clinic 19
Testing effectiveness (Phase 2)Study completedNCT01557959What this trial is testingDocetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerWho this might be right forAdenocarcinoma of the LungAdenosquamous Cell Lung CancerBronchoalveolar Cell Lung Cancer+6 more Wake Forest University Health Sciences 45
Testing effectiveness (Phase 2)Study completedNCT00003989What this trial is testingISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic MelanomaWho this might be right forLung CancerMelanoma (Skin) European Organisation for Research and Treatment of Cancer - EORTC 50
Not applicableStudy completedNCT04640935What this trial is testingPaclitaxel in Combination With Bevacizumab in Patients With Stage IV NSCLC.Who this might be right forNon Small Cell Lung Cancer Centre Hospitalier Annecy Genevois 320
Large-scale testing (Phase 3)UnknownNCT00112710What this trial is testingGemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forLung Cancer University Hospital Birmingham 1,350
Not applicableStudy completedNCT00450567What this trial is testingGlucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and ChemotherapyWho this might be right forLung Cancer Jonsson Comprehensive Cancer Center 36
Testing effectiveness (Phase 2)Study completedNCT00004201What this trial is testingGemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung CancerWho this might be right forLung Cancer Herbert Irving Comprehensive Cancer Center
Large-scale testing (Phase 3)UnknownNCT00022009What this trial is testingGemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung CancerWho this might be right forLung Cancer The Christie NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT02452463What this trial is testingNintedanib Compared With Placebo in Treating Against Radiation-Induced Pneumonitis in Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery and Are Undergoing Chemoradiation TherapyWho this might be right forLung Non-Squamous Non-Small Cell CarcinomaRadiation-Induced PneumonitisStage II Lung Non-Small Cell Cancer AJCC v7+6 more Roswell Park Cancer Institute 8
Not applicableActive Not RecruitingNCT02178163What this trial is testingComprehensive Genomic Analysis in Tissue Samples From Patients With Recurrent or Stage IV Non-small Cell Lung CancerWho this might be right forRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer Barbara Ann Karmanos Cancer Institute 619
Testing effectiveness (Phase 2)Ended earlyNCT00955305What this trial is testingPaclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung CancerWho this might be right forLarge Cell Lung CarcinomaLung AdenocarcinomaRecurrent Non-Small Cell Lung Carcinoma+2 more National Cancer Institute (NCI) 175
Large-scale testing (Phase 3)Looking for participantsNCT07738172What this trial is testingOsimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung CancerWho this might be right forLung Neoplasms, Non-Small Cell Lung Cancer National Taiwan University Hospital 154
Testing effectiveness (Phase 2)UnknownNCT01210053What this trial is testingSunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerWho this might be right forNon-small Cell Lung Cancer Third Military Medical University 30
Early research (Phase 1)Study completedNCT00667641What this trial is testingPaclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid TumorsWho this might be right forBreast CancerColorectal CancerHead and Neck Cancer+6 more University of Medicine and Dentistry of New Jersey 16
Early research (Phase 1)Study completedNCT04384146What this trial is testingRadiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)Who this might be right forNon-Small Cell Lung Cancer Memorial Sloan Kettering Cancer Center 41
Testing effectiveness (Phase 2)Study completedNCT02823990What this trial is testingTG4010 and Nivolumab in Patients With Lung CancerWho this might be right forRecurrent Non-Small Cell Lung CarcinomaStage I Non-Small Cell Lung CancerStage II Non-Small Cell Lung Cancer+3 more Megan Daly, MD 13
Testing effectiveness (Phase 2)Study completedNCT02655913What this trial is testingSafety and Efficacy of Vitamin C Infusion in Combination With Local mEHT to Treat Non Small Cell Lung CancerWho this might be right forCarcinoma, Non-Small-Cell LungStage IIIA Non-small Cell Lung CancerStage IIIB Non-small Cell Lung Cancer+2 more Clifford Hospital, Guangzhou, China 97
Testing effectiveness (Phase 2)Study completedNCT01282450What this trial is testingConcurrent and Non-concurrent Chemo-radiotherapy or Radiotherapy Alone for Patients With Oligo-metastatic Stage IV Non-small Cell Lung Cancer (NSCLC)Who this might be right forStage IV (Oligo-metastases)Non-small Cell Lung Cancer Maastricht Radiation Oncology 60